Pricing Log in Create free account

ClearPoint Neuro, Inc. (CLPT) vs Treace Medical Concepts, Inc. (TMCI)

ClearPoint Neuro, Inc. and Treace Medical Concepts, Inc. are both Medical Devices companies. ClearPoint Neuro, Inc. and Treace Medical Concepts, Inc. are of similar size ($278.6M and $271.9M). ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 32.5% against −3.95%. Treace Medical Concepts, Inc. has the higher net margin (−29.0% vs −79.4%) and the higher return on invested capital (−43.0% vs −62.8%). Across the 18 metrics below, Treace Medical Concepts, Inc. leads on 15 and ClearPoint Neuro, Inc. on 3.

Valuation

Metric CLPT TMCI Medical Devices median
P/E n/m n/m 25.58
P/S 5.92 1.31 2.54
P/B 9.87 3.98 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 6.02 1.37 2.72
Earnings yield (13.93%) (22.46%) (12.82%)
Free cash flow yield (12.54%) (9.30%) (8.18%)

Profitability

Metric CLPT TMCI Medical Devices median
Gross margin 61.39% 79.45% 57.76%
Operating margin (70.56%) (26.17%) (15.07%)
Net margin (79.43%) (28.99%) (14.45%)
Free cash flow margin (73.02%) (12.20%) (3.88%)
Return on equity (167.52%) (71.99%) (10.35%)
Return on assets (41.75%) (30.72%) (17.26%)
Return on invested capital (62.84%) (42.96%) (5.27%)

Growth

Metric CLPT TMCI Medical Devices median
Revenue growth (TTM) 32.51% (3.95%) 10.41%
EPS growth (last fiscal year) (28.57%) (3.33%) 28.17%
Revenue growth, 5-year CAGR 23.58% 29.96% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLPT TMCI Medical Devices median
Debt to equity 1.86 0.83 0.04
Current ratio 6.76 2.90 2.74
Net debt to EBITDA (0.14) (0.17) 0.54

Dividend

Metric CLPT TMCI Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric CLPT TMCI Medical Devices median
Market cap 278.55m 271.85m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack